Borgeson Blake 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Dec 4, 2025
Insider Transaction Report
Form 4
Borgeson Blake
Director
Transactions
- Sale
Class A Common Stock
2025-12-02$4.37/sh−220,000$961,400→ 6,869,863 total
Footnotes (1)
- [F1]This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025.